CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $403,975
- in 4 filings, $404K under 10b5-1 plans
Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-07 | Nash Huw M. COO & CBO | Sale | −913 | $22.41 | $20K | 0 |
| 2020-07-01 | Nash Huw M. COO & CBO | Exercise or conversion | +3,800 | $2.19 | $8K | 3,800 |
| 2020-07-01 | Nash Huw M. COO & CBO | Sale | −3,800 | $23.15 | $88K | 0 |
| 2020-07-01 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −3,800 | 224,911 | ||
| 2020-06-03 | TZIANABOS ARTHUR Director | Grant or award · Director Stock Option (Right to Buy) | +14,777 | 14,777 | ||
| 2020-06-03 | Smith Julie Director | Grant or award · Director Stock Option (Right to Buy) | +29,555 | 29,555 | ||
| 2020-06-03 | LEVIN ARTHUR A Director | Grant or award · Director Stock Option (Right to Buy) | +14,777 | 14,777 | ||
| 2020-06-03 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +14,777 | 14,777 | ||
| 2020-06-03 | Harrison Seth Loring Director | Grant or award · Director Stock Option (Right to Buy) | +14,777 | 14,777 | ||
| 2020-06-03 | Burstein Jennifer Director | Grant or award · Director Stock Option (Right to Buy) | +14,777 | 14,777 | ||
| 2020-06-01 | Ticho Barry Chief Medical Officer | Exercise or conversion | +131,147 | $0.60 | $79K | 131,147 |
| 2020-06-01 | Ticho Barry Chief Medical Officer | Exercise or conversion | +42,880 | $2.19 | $94K | 174,027 |
| 2020-06-01 | Ticho Barry Chief Medical Officer | Sale | −1,000 | $27.17 | $27K | 173,027 |
| 2020-06-01 | Ticho Barry Chief Medical Officer | Sale | −365 | $27.98 | $10K | 172,662 |
| 2020-06-01 | Ticho Barry Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −131,147 | 85,946 | ||
| 2020-06-01 | Ticho Barry Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −42,880 | 85,765 | ||
| 2020-06-01 | Liau Gene EVP Research & Preclinical Dev | Exercise or conversion | +20,000 | $2.19 | $44K | 33,500 |
| 2020-06-01 | Liau Gene EVP Research & Preclinical Dev | Sale | −10,895 | $25.82 | $281K | 22,605 |
| 2020-06-01 | Liau Gene EVP Research & Preclinical Dev | Sale | −7,875 | $26.91 | $212K | 14,730 |
| 2020-06-01 | Liau Gene EVP Research & Preclinical Dev | Sale | −1,230 | $27.48 | $34K | 13,500 |
Page 31 of 35 · 681 trades